How does Rexulti® Compared to Other Atypical Antipsychotics
Rexulti® (REK-suhl-tee, brexpiprazole) will be another oral atypical antipsychotic for treating schizophrenia in adults. It’s a [...]
Jul
What to expect from Alzheimer’s Medicines
There's not a hard-and-fast rule to know whether to start or stop meds for Alzheimer's [...]
Jul
COVID-19 information- How to make sense of it all?
A deluge of COVID-19 social media posts will have you wondering you how to identify [...]
Jul
Rybelsus® -Oral Semaglutide
Rybelsus® (semaglutide) will be the first ORAL GLP-1 agonist for type 2 diabetes…it’s a tablet version [...]
Jun
Mayzent® Pros & Cons
Mayzent® (siponimod) will be a new oral treatment for secondary progressive multiple sclerosis (MS) in adults. [...]
May
SGLT2 Inhibitor Risks
SGLT2 inhibitor (Jardiance®, Invokana®, Forxiga®, etc) risks are in the spotlight again. SGLT2 stands for [...]
May
Assessment of Evidence for COVID-19-Related Treatments: Updated 5/15/2020
The information contained in this evidence table is emerging and rapidly evolving because of ongoing [...]
May
Hydroxychloroquine- COVID-19 Treatment evidence (April 2020)
Current treatment evidence of hydroxychloroquine in COVID-19 (April 14 2020)
Apr
Frostbite- What you need to know (Part 2)
Frosbite Prevention Frostbite and related cold injuries can generally be prevented with planning prior to [...]
Mar
Inflammatory Bowel Disease- What do I do if I am pregnant or breastfeeding?
Inflammatory bowel disease (IBD) in pregnant women increases the risk of preterm birth, low birth [...]
Feb
